<ul> <li style="text-align:justify"><strong>Researchers at the Spanish National Cancer Research Center (CNIO) and the 12 de Octubre University Hospital have developed a new cell-based immunotherapy to treat multiple myeloma </strong><br /> </li> <li><strong>The new immunotherapy is based on <em>STAb cells</em> and has yet to pass clinical trials. </strong><br /> </li> <li><strong>The study is published in <em>Science Translational Medicine</em>, with head of the H12O-CNIO Cancer Immunotherapy Clinical Research Unit Luis Álvarez-Vallina as senior author.</strong></li>
</ul>